The forecast for Canada's top-cited scientific publications in drug discovery indicates a gradual decline from 2024 to 2028, decreasing from 11.62 to 11.4 publications. Compared to 2023, where the estimated figure was slightly higher, this gradual decline reflects a minimal year-on-year decrease. Over the five-year forecast period, the compound annual growth rate (CAGR) suggests a steady but modest negative growth pattern.
Future Trends to Watch:
- Impact of new governmental policies on research funding and infrastructure.
- Integration of AI and machine learning techniques in drug discovery research.
- Collaborative efforts and international partnerships in scientific publications.
